(Q42860784)

8 November 2017

KRAS status analysis and anti-EGFR therapies: is comprehensiveness a biologist's fancy or a clinical necessity? (English)

1 reference

8 November 2017

4

1 reference

8 November 2017

E Lopez-Crapez

1

1 reference

8 November 2017

L Mineur

series ordinal

2

1 reference

8 November 2017

H Emptas

series ordinal

3

1 reference

8 November 2017

language of work or name

English

0 references

publication date

16 February 2010

1 reference

British Journal of Cancer

8 November 2017

1 reference

8 November 2017

102

1 reference

8 November 2017

6

1 reference

8 November 2017

1074-5; author reply 1076-7

1 reference

COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer

8 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2844033

KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2844033

KRAS mutations and sensitivity to epidermal growth factor receptor inhibitors in colorectal cancer: practical application of patient selection

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2844033

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2844033

Replacing PCR with COLD-PCR enriches variant DNA sequences and redefines the sensitivity of genetic testing

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2844033

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2844033

KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2844033

Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2844033

High-resolution genotyping by amplicon melting analysis using LCGreen

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2844033

Biochemical characterization of a novel KRAS insertion mutation from a human leukemia

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2844033

RAS oncogenes: the first 30 years.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2844033

Oncogenic insertional mutations in the P-loop of Ras are overactive in MAP kinase signaling

16 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20160721

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

High-resolution melting analysis for rapid detection of KRAS, BRAF, and PIK3CA gene mutations in colorectal cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20160721

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/SJ.BJC.6605582

1 reference

8 November 2017

1 reference

8 November 2017

PubMed publication ID

20160721

1 reference